Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) Shares Outstanding (2009 - 2026)

Updated

Elite Pharmaceuticals' Weighted Average Shares Outstanding came in at 1.08 billion for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 0.5% from 1.07 billion a year earlier and unchanged from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Shares Outstanding (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Weighted Average Shares Outstanding was 1.07 billion, up 0.4% from FY2025.

  • Weighted Average Shares Outstanding has increased in each of the last eight fiscal years, with a five-year compound annual growth rate of 2.6% (FY2021 to FY2026).
  • Going back by fiscal year, Weighted Average Shares Outstanding was 1.07 billion in FY2025 (+5.2%), 1.02 billion in FY2024 (+0.2%), 1.01 billion in FY2023 (+0.2%) and 1.01 billion in FY2022 (+7.2%).
  • The five-year range for quarterly Weighted Average Shares Outstanding is 1.01 billion (fiscal Q4 2022) to 1.08 billion (fiscal Q1 2027).
  • Year-over-year, Weighted Average Shares Outstanding has increased for five consecutive quarters, with growth averaging 1.6% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding ran from 0.0% in fiscal Q1 2026 to 7.2% in fiscal Q4 2022.
  • Business Quant data shows ELTP's Weighted Average Shares Outstanding at 1.08 billion (Q1 2027), 1.07 billion (Q4 2026) and 1.07 billion (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.41 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 1.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 1.94 Bn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.55 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.24 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.70 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 1.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.08 Bn
Jun 30, 2026 1.08 Bn
Mar 31, 2026 1.07 Bn
Dec 31, 2025 1.07 Bn
Sep 30, 2025 1.07 Bn
Jun 30, 2025 1.07 Bn
Mar 31, 2025 1.07 Bn
Dec 31, 2024 1.07 Bn
Sep 30, 2024 1.07 Bn
Jun 30, 2024 1.07 Bn
Mar 31, 2024 1.02 Bn
Dec 31, 2023 1.01 Bn
Sep 30, 2023 1.01 Bn
Jun 30, 2023 1.01 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 1.01 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 1.01 Bn
Dec 31, 2021 1.01 Bn
API Access

Elite Pharmaceuticals Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ELTP&period=max&api_key=YOUR_API_KEY